{"product_id":"cdkn2a-p16ink4a-cdkn2b-p15ink4b-antibody-sc-f2342","title":"CDKN2A\/p16INK4A + CDKN2B\/p15INK4B Antibody","description":"\u003ch2\u003eAbout the Target\u003c\/h2\u003e\u003cp\u003eCDKN2A\/p16INK4A + CDKN2B\/p15INK4B is a target of interest in many antibody-based workflows. CDKN2A is part of a gene family that encodes structurally related inhibitors of cyclin-dependent kinases (CDKs), which play a critical role in regulating the G1\/S-phase transition of the cell cycle. The CDKN2A gene produces the p16INK4A protein, a regulator that inhibits the activity of CDK4 and CDK6 to control this phase transition. Depending on the literature source, CDKN2A\/p16INK4A + CDKN2B\/p15INK4B may also be discussed as CDKN2A\/p16INK4A + CDKN2B\/p15INK4B and CDKN2B\/CDKN2A\/p16.\u003c\/p\u003e\u003cp\u003eReported cellular context includes cytoplasm and nucleus, which can matter when signal is compared across treatments or changing cell states. Following CDKN2A\/p16INK4A + CDKN2B\/p15INK4B across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state.\u003c\/p\u003e\u003ch2\u003eResearch Context\u003c\/h2\u003e\u003cp\u003eCDKN2A\/p16INK4A + CDKN2B\/p15INK4B is commonly interpreted in the context of cancer, cell cycle, and cell signaling research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans cytoplasm and nucleus, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.\u003c\/p\u003e\u003cp\u003eConsider these angles when interpreting target-level changes:\u003c\/p\u003e\u003cul\u003e\n\u003cli\u003eapparent redistribution between cytoplasm and nucleus across matched conditions\u003c\/li\u003e\n\u003cli\u003echanges associated with proliferative state, oncogenic signaling, or treatment response\u003c\/li\u003e\n\u003cli\u003ecell-cycle linked differences in abundance, timing, or compartmental enrichment\u003c\/li\u003e\n\u003cli\u003esignal-dependent shifts after ligand, inhibitor, or growth-factor perturbation\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch2\u003eVariant Considerations\u003c\/h2\u003e\u003cp\u003eIf your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for CDKN2A\/p16INK4A + CDKN2B\/p15INK4B. This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.\u003c\/p\u003e\u003cp\u003eStandardize sampling time, control choice, and downstream analysis thresholds so apparent differences in CDKN2A\/p16INK4A + CDKN2B\/p15INK4B reflect biology rather than handling. When interpreting CDKN2A\/p16INK4A + CDKN2B\/p15INK4B, it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.\u003c\/p\u003e\u003cp\u003eFor multi-run studies, a shared reference condition can keep CDKN2A\/p16INK4A + CDKN2B\/p15INK4B trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.\u003c\/p\u003e","brand":"Selleck Chemicals","offers":[{"title":"20 µl","offer_id":57577910960473,"sku":"F2342-20UL","price":199.0,"currency_code":"EUR","in_stock":true},{"title":"100 µl","offer_id":57577910993241,"sku":"F2342-100UL","price":489.0,"currency_code":"EUR","in_stock":true},{"title":"2 × 100 µl","offer_id":57577911026009,"sku":"F2342-2X100UL","price":729.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0923\/1011\/0553\/files\/F2342-IF.png?v=1773600311","url":"https:\/\/absource.de\/products\/cdkn2a-p16ink4a-cdkn2b-p15ink4b-antibody-sc-f2342","provider":"Absource Diagnostics","version":"1.0","type":"link"}